From the TetraLogic Pharmaceuticals Corporation, Malvern, PA; and Departments of Medicine and Health Research and Policy, Stanford University School of Medicine, Department of Statistics, Stanford University School of Humanities and Sciences, and Meta-Research Innovation Center at Stanford (METRICS), CA.
Circ Res. 2015 Jan 2;116(1):116-26. doi: 10.1161/CIRCRESAHA.114.303819.
Medical and scientific advances are predicated on new knowledge that is robust and reliable and that serves as a solid foundation on which further advances can be built. In biomedical research, we are in the midst of a revolution with the generation of new data and scientific publications at a previously unprecedented rate. However, unfortunately, there is compelling evidence that the majority of these discoveries will not stand the test of time. To a large extent, this reproducibility crisis in basic and preclinical research may be as a result of failure to adhere to good scientific practice and the desperation to publish or perish. This is a multifaceted, multistakeholder problem. No single party is solely responsible, and no single solution will suffice. Here we review the reproducibility problems in basic and preclinical biomedical research, highlight some of the complexities, and discuss potential solutions that may help improve research quality and reproducibility.
医学和科学的进步取决于新的知识,这些知识必须是稳健可靠的,并且能够为进一步的发展提供坚实的基础。在生物医学研究中,我们正处于一场革命之中,新数据和科学出版物以前所未有的速度不断涌现。然而,不幸的是,有令人信服的证据表明,这些发现中的大多数将无法经受住时间的考验。在很大程度上,基础研究和临床前研究中的这种可重复性危机可能是由于未能坚持良好的科学实践以及急于发表或灭亡的心态所致。这是一个多方面的、多利益相关者的问题。没有一个单一的责任方,也没有一个单一的解决方案可以解决问题。在这里,我们回顾了基础研究和临床前生物医学研究中的可重复性问题,强调了其中的一些复杂性,并讨论了可能有助于提高研究质量和可重复性的潜在解决方案。
Nat Rev Drug Discov. 2015-9-21
Nat Rev Clin Oncol. 2013-10-1
Acta Med Croatica. 2006
Eur Neuropsychopharmacol. 2015-10
Verh K Acad Geneeskd Belg. 2004
PLoS Biol. 2016-6-14
Imaging Neurosci (Camb). 2024-12-16
Philos Trans A Math Phys Eng Sci. 2025-7-31
Cardiovasc Diabetol. 2025-7-18